How Much Does Provigil (Modafinil) Cost in Texas in 2026?

Brand vs. Generic Pricing in Texas

Generic modafinil costs roughly 90% less than brand-name Provigil at Texas pharmacies. The manufacturer list price for brand Provigil from Cephalon sits near $850 per month for a 30-day supply of 200 mg tablets. Generic modafinil, available since 2012 after patent expiration, averages approximately $80 per month at cash-pay retail pharmacies across the state in 2026.

That spread matters. Modafinil was first approved by the FDA in December 1998 for narcolepsy, following key trial data from the US Modafinil in Narcolepsy Multicenter Study Group. That trial (published in Annals of Neurology, 1998) randomized 283 patients and demonstrated that modafinil 200 mg and 400 mg significantly reduced daytime sleepiness compared to placebo on the Maintenance of Wakefulness Test. The drug later gained additional approvals for obstructive sleep apnea (as adjunctive therapy) and shift-work disorder.

Pricing varies by pharmacy. H-E-B, Walmart, CVS, and Walgreens locations across Texas report generic modafinil prices ranging from $55 to $120 per month for 30 tablets of 200 mg without insurance, depending on location and whether the pharmacy participates in a discount program. Costco pharmacies in Houston, Dallas, and San Antonio tend to cluster at the lower end. Prices shift quarterly, so calling ahead or checking an online price comparison tool before filling is worth the two minutes.

Texas Medicaid and Modafinil Coverage

Texas Medicaid does not cover Provigil or generic modafinil for narcolepsy, shift-work disorder, or off-label cognitive enhancement. The Texas Medicaid Preferred Drug List (PDL) restricts modafinil coverage, and prior authorization requests for these indications are routinely denied under current formulary rules.

This gap affects a sizable group. According to CDC data on sleep disorders, an estimated 70 million Americans live with chronic sleep disorders, and narcolepsy specifically affects roughly 1 in 2,000 people. Texas, with a population exceeding 30 million, has an estimated 15,000 residents with narcolepsy. For Medicaid beneficiaries in that group, the lack of coverage creates a real access barrier.

Patients on Texas Medicaid who need a wakefulness-promoting agent may find limited options through the exceptions process. A prescriber can submit a prior authorization with supporting polysomnography and Multiple Sleep Latency Test (MSLT) results, but approval rates remain low based on current formulary restrictions. The Endocrine Society and the American Academy of Sleep Medicine both recognize modafinil as first-line therapy for excessive daytime sleepiness in narcolepsy, yet state Medicaid programs retain broad discretion over formulary inclusion.

"Formulary placement for wakefulness agents varies dramatically by state, and Texas is among the more restrictive programs for Schedule IV stimulant-class drugs," notes guidance from the American Academy of Family Physicians on managing narcolepsy in primary care.

Private Insurance Coverage for Provigil in Texas

Most major commercial insurers in Texas cover generic modafinil with prior authorization, though brand Provigil frequently requires step therapy or is excluded entirely. Blue Cross Blue Shield of Texas, Aetna, UnitedHealthcare, and Cigna plans available through the Texas marketplace generally place generic modafinil on Tier 2 or Tier 3, with copays ranging from $15 to $75 per month after prior authorization.

The prior authorization process typically requires documentation of one of the three FDA-approved indications. Off-label prescribing for cognitive enhancement, fatigue related to depression, or ADHD is almost universally denied by commercial insurers. A 2020 analysis published in JAMA Network Open found that prior authorization requirements for wake-promoting agents resulted in a 23% initial denial rate across commercial plans, though 61% of appeals were eventually approved when adequate clinical documentation accompanied the request.

For patients with employer-sponsored plans, the specific formulary tier and copay depend on the plan design. Self-insured employer plans (common among large Texas employers) may have different coverage rules than fully insured marketplace plans. Checking the plan's formulary before the first fill prevents surprises at the pharmacy counter.

Compounded Modafinil in Texas: Legal Status and Access

Compounded modafinil is legal in Texas through licensed 503A pharmacies operating under both federal and Texas State Board of Pharmacy oversight. A 503A pharmacy compounds patient-specific prescriptions based on a valid prescriber order, and modafinil qualifies because it is not on the FDA's "do not compound" list.

Texas regulates compounding pharmacies with above-average rigor. The Texas State Board of Pharmacy requires 503A facilities to comply with United States Pharmacopeia (USP) chapters 795 and 797 for non-sterile and sterile compounding respectively. Inspections occur on a scheduled and unannounced basis. The board has enforcement authority to suspend or revoke licenses for non-compliance, and has done so in cases involving potency failures or contamination.

There are practical considerations. Compounded modafinil is not AB-rated to the FDA-approved reference product, meaning bioequivalence has not been established through the standard ANDA pathway. The FDA's guidance on compounding makes clear that 503A pharmacies must compound in response to individual patient prescriptions and cannot produce large batches for general distribution. Patients choosing compounded modafinil should confirm that their pharmacy holds a current Texas Board of Pharmacy license and complies with applicable USP standards.

Pricing for compounded modafinil varies widely. Some 503A pharmacies in Texas offer 30-day supplies at costs below generic retail pricing, particularly for patients paying cash. Others charge comparable or higher prices depending on the formulation and whether custom dosing (e.g., 150 mg or 250 mg capsules not commercially available) is requested.

Telehealth Prescribing of Modafinil in Texas

Texas law permits telehealth prescribing of modafinil. Because modafinil is a Schedule IV controlled substance under the federal Controlled Substances Act, it falls within the scope of substances that Texas-licensed prescribers can prescribe via synchronous audio-video telehealth encounters.

The DEA's telemedicine prescribing rules, initially expanded during COVID-19, have been extended through rulemaking that allows initial prescribing of Schedule III through V controlled substances via telehealth without a prior in-person exam. Texas Medical Board rules align with this framework. A Texas-licensed physician or advanced practice provider conducting a synchronous video visit can issue a modafinil prescription to a Texas patient, and the prescription can be sent electronically to any Texas pharmacy.

Several telehealth platforms operating in Texas offer modafinil consultations. Pricing for the telehealth visit itself ranges from $50 to $200, separate from the medication cost. Patients should verify that the prescribing clinician holds a valid Texas medical license and that the platform uses a DEA-registered prescriber for controlled substance orders.

One practical note: some telehealth platforms will not prescribe modafinil for off-label uses. If the indication is narcolepsy or shift-work disorder, documentation from a prior sleep study strengthens the prescribing clinician's ability to write the prescription during a telehealth encounter.

How to Reduce Your Modafinil Cost in Texas

Multiple strategies can bring the out-of-pocket cost below the $80 average for generic modafinil. GoodRx, RxSaver, and similar prescription discount platforms frequently show Texas pharmacy prices between $25 and $60 for 30 tablets of generic modafinil 200 mg when using a coupon code.

Manufacturer savings programs exist but primarily apply to brand-name products. Cephalon (now part of Teva Pharmaceutical Industries) has periodically offered copay cards for brand Provigil, though these programs exclude government-insured patients (Medicaid, Medicare, Tricare). For commercially insured patients, a copay card can reduce the brand copay to as low as $0 to $25 per month, depending on the specific program terms.

Pill splitting is another approach. Modafinil 200 mg tablets are scored and can be split into two 100 mg doses. For patients prescribed 100 mg daily, purchasing the 200 mg tablet and splitting yields a 50% cost reduction. The FDA's general guidance on tablet splitting notes that scored tablets are designed for this purpose, and modafinil's scored 200 mg tablet is a candidate.

Patient assistance programs through Teva may be available for uninsured patients who meet income criteria. NeedyMeds and RxAssist maintain updated databases of available programs. Eligibility typically requires household income below 200% to 400% of the federal poverty level and lack of prescription drug coverage.

Texas-specific options include community health centers operating under the 340B Drug Pricing Program. Federally qualified health centers (FQHCs) in Houston, Dallas, San Antonio, Austin, and El Paso can access 340B pricing on modafinil, passing significant savings to qualifying patients. The HRSA 340B program maintains a searchable database of participating entities.

Modafinil Dosing, Safety, and Monitoring

Standard modafinil dosing is 200 mg taken once in the morning for narcolepsy and obstructive sleep apnea. For shift-work disorder, the FDA-approved labeling recommends 200 mg taken approximately one hour before the start of the work shift.

Common adverse effects include headache (34% vs. 23% placebo), nausea (11% vs. 3% placebo), and nervousness (7% vs. 3% placebo), based on pooled clinical trial data from the original NDA review. Serious but rare adverse effects include Stevens-Johnson syndrome and drug reaction with eosinophilia and systemic symptoms (DRESS), both of which carry FDA black-box-level warnings in the prescribing information.

"For patients starting modafinil, we recommend a baseline assessment of cardiovascular risk, blood pressure, and any history of psychiatric symptoms, particularly in patients with pre-existing anxiety or mood disorders," states the American Academy of Sleep Medicine clinical practice guideline on the treatment of central disorders of hypersomnolence.

Drug interactions warrant attention. Modafinil is a moderate inducer of CYP3A4 and can reduce the efficacy of hormonal contraceptives, cyclosporine, and some HIV antivirals. Women using oral contraceptives should use an alternative or additional contraceptive method during modafinil therapy and for one month after discontinuation, per FDA labeling. This interaction is clinically significant and under-recognized.

Modafinil does not require routine blood monitoring, but periodic reassessment of the underlying sleep disorder (typically annually) ensures continued appropriateness of therapy. For patients with hepatic impairment, the recommended dose is 100 mg daily.

Texas-Specific Regulatory Considerations

Texas classifies modafinil as a Schedule IV controlled substance, matching federal scheduling. The Texas Prescription Monitoring Program (PMP) tracks all modafinil dispensing statewide. Prescribers are required to check the Texas PMP before issuing a new modafinil prescription, and pharmacists must report dispensing data within one business day.

Refill rules for Schedule IV substances in Texas allow up to five refills within six months from the date of issue. A new prescription is required after six months or after five refills, whichever comes first. Partial fills are permitted under Texas rules, which can help patients manage cash-flow timing on higher-cost prescriptions.

Texas does not impose additional state-level restrictions on modafinil beyond federal DEA requirements. There is no state-mandated quantity limit, though individual insurers and pharmacy benefit managers may apply their own quantity limits (typically 30 tablets per 30 days).